Phase II randomized trial of docetaxel plus estramustine (DE) versus docetaxel (D) in patients (pts) with hormone-refractory prostate cancer (HRPC): a final report

Phase II randomized trial of docetaxel plus estramustine (DE) versus docetaxel (D) in patients (pts) with hormone-refractory prostate cancer (HRPC): a final report

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.4603 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4603-4603 ◽

Cited By ~ 4

Author(s):

J.-C. Eymard ◽

F. Joly ◽

F. Priou ◽

A. Zannetti ◽

A. Ravaud ◽

...

Keyword(s):

Prostate Cancer ◽

Randomized Trial ◽

Phase Ii ◽

Final Report ◽

Phase II Randomized Trial of Weekly Paclitaxel with or Without Estramustine Phosphate in Progressive, Metastatic, Hormone-Refractory Prostate Cancer

Clinical Prostate Cancer ◽

10.3816/cgc.2004.n.020 ◽

2004 ◽

Vol 3 (2) ◽

pp. 104-111 ◽

Cited By ~ 38

Author(s):

William R. Berry ◽

James W. Hathorn ◽

Shaker R. Dakhil ◽

David M. Loesch ◽

Don V. Jackson ◽

...

Keyword(s):

Prostate Cancer ◽

Randomized Trial ◽

Phase Ii ◽

Weekly Paclitaxel ◽

Estramustine Phosphate ◽

A Phase II study of the safety, pharmacokinetics and efficacy of IncelTM (biricodar, VX-710) in combination with mitoxantrone (M) and prednisone (P) in advanced hormone refractory prostate cancer (HRPC)

European Journal of Cancer ◽

10.1016/s0959-8049(99)81827-9 ◽

1999 ◽

Vol 35 ◽

pp. S349 ◽

Cited By ~ 1

Author(s):

A. Einstein ◽

R. Lush ◽

R. Rago ◽

G. Bubley ◽

W.D. Henner ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Lycopene for Advanced Hormone Refractory Prostate Cancer: A Prospective, Open Phase II Pilot Study

The Journal of Urology ◽

10.1016/j.juro.2008.11.012 ◽

2009 ◽

Vol 181 (3) ◽

pp. 1098-1103 ◽

Cited By ~ 17

Author(s):

Carla Schwenke ◽

Burkhard Ubrig ◽

Petra Thürmann ◽

Christian Eggersmann ◽

Stephan Roth

Keyword(s):

Prostate Cancer ◽

Pilot Study ◽

Phase Ii ◽

Open Phase ◽

Phase II trial of anti-idiotypic p53 peptides (Pentrys) plus granulocyte-macrophage colony-stimulating factor in patients with hormone-refractory prostate cancer

Asia-Pacific Journal of Clinical Oncology ◽

10.1111/j.1743-7563.2007.00101.x ◽

2007 ◽

Vol 3 (3) ◽

pp. 148-155

Author(s):

Ian D DAVIS ◽

Guy TONER ◽

Adam BROAD ◽

Louise M CAMPANO ◽

Mark ROSENTHAL

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Colony Stimulating Factor ◽

Macrophage Colony Stimulating Factor ◽

Hormone Refractory ◽

Macrophage Colony ◽

Stimulating Factor ◽

P53 Peptides

Docetaxel, Vinorelbine, and Zoledronic Acid as First-Line Treatment in Patients with Hormone Refractory Prostate Cancer: A Phase II Study

European Urology ◽

10.1016/j.eururo.2007.02.060 ◽

2007 ◽

Vol 52 (4) ◽

pp. 1020-1027 ◽

Cited By ~ 13

Author(s):

Giuseppe Di Lorenzo ◽

Riccardo Autorino ◽

Sisto Perdonà ◽

Michele De Laurentiis ◽

Massimo D'Armiento ◽

...

Keyword(s):

Prostate Cancer ◽

Zoledronic Acid ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Hormone Refractory ◽

First Line Treatment

A phase II study of continuous infusion 5-fluorouracil in advanced hormone refractory prostate cancer. An illinois cancer center study

Cancer ◽

10.1002/1097-0142(19930915)72:6<1965::aid-cncr2820720629>3.0.co;2-x ◽

1993 ◽

Vol 72 (6) ◽

pp. 1965-1968 ◽

Cited By ~ 26

Author(s):

Timothy M. Kuzel ◽

Martin S. Tallman ◽

Daniel Shevrin ◽

Edward Braud ◽

Lary Kilton ◽

...

Keyword(s):

Prostate Cancer ◽

Continuous Infusion ◽

Phase Ii ◽

Phase Ii Study ◽

Cancer Center ◽

Hormone Refractory ◽

Center Study

Phase II study of oral bis (aceto) ammine dichloro (cyclohexamine) platinum (IV) (JM-216, BMS-182751) given daily x 5 in hormone refractory prostate cancer (HRPC)

Investigational New Drugs ◽

10.1023/b:drug.0000047109.76766.84 ◽

2005 ◽

Vol 23 (1) ◽

pp. 79-84 ◽

Cited By ~ 51

Author(s):

Tahir Latif ◽

Laura Wood ◽

Cindy Connell ◽

David C. Smith ◽

David Vaughn ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Phase II Study of Vinorelbine and Low-Dose Docetaxel in Chemotherapy-Naive Patients with Hormone-Refractory Prostate Cancer

The Cancer Journal ◽

10.1097/00130404-200307000-00011 ◽

2003 ◽

Vol 9 (4) ◽

pp. 286-292 ◽

Cited By ~ 14

Author(s):

Alan J. Koletsky ◽

Manuel L. Guerra ◽

Lori Kronish

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Low Dose ◽

Phase Ii Study ◽

Phase II study of vlnorelbine in patients with hormone refractory prostate cancer

European Journal of Cancer ◽

10.1016/s0959-8049(97)84523-6 ◽

1997 ◽

Vol 33 ◽

pp. S33

Author(s):

A. Caty ◽

S. Oudard ◽

Y. Humblet ◽

M. Beauduin ◽

E. Suc ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Study ◽